Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

VIJAYA DIAGNOSTIC CENTRE LTD.

NSE : VIJAYABSE : 543350ISIN CODE : INE043W01024Industry : Hospital & Healthcare ServicesHouse : Private

BSE986.25-8.7 (-0.87 %)

PREV CLOSE ( ) 994.95

OPEN PRICE ( ) 994.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 7412

TODAY'S LOW / HIGH ( )973.40 994.95

52 WK LOW / HIGH ( )800 1276.75

NSE988.65-6.15 (-0.62 %)

PREV CLOSE( ) 994.80

OPEN PRICE ( ) 996.00

BID PRICE (QTY) 988.65 (20)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 105025

TODAY'S LOW / HIGH( ) 974.30 996.00

52 WK LOW / HIGH ( )740 1275

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 05-06 2002

Management Info

Sura Surendranath Reddy - Chairman Sura S Reddy - Managing Director

Registered Office

Address 6-3-883/ F , F P A Building,Near Topaz Building,Punjagutta,
Hyderabad,
Telangana-500082

Phone 040 2342 0411-12

Email info@vijayadiagnostic.com

Website www.vijayadiagnostic.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

16Oct Vijaya Diagnostic Centre informs about
In furtherance to communication dated September 29, 2025, Vijaya Diagnos..

03Oct Vijaya Diagnostic Centre informs about
Vijaya Diagnostic Centre has certified that the details of securities de..

20Sep Vijaya Diagnostic Centre informs abou
Vijaya Diagnostic Centre has informed that a regional daily newspaper (‘..

29Jul Vijaya Diagnostic Centre informs about
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligat..

18Jul Vijaya Diagnostic Centre submits analy
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	383.9	1350.12
Gross Profit	515.69	1813.02
Operating Profit	767.98	2718.1
Net Sales	1748.45	6271.38

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 5235.70 (1.21%)	M.Cap ( in Cr)2530.32
Dr. Lal Pathlabs (BSE) 3137.05 (1.56%)	M.Cap ( in Cr)26280.80
Thyrocare Tech. (BSE) 1396.60 (3.54%)	M.Cap ( in Cr)7409.51
Indraprastha Medical (BSE) 603.90 (2.22%)	M.Cap ( in Cr)5536.13
Yatharth Hospital (BSE) 796.75 (1.14%)	M.Cap ( in Cr)7677.03

Shareholding Pattern

	PROMOTERS	52.6%
	MUTUAL FUNDS/UTI	24.8%
	NON-INSTITUTION	3.79%
	FI/BANKS/INSURANCE	0.51%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Nippon India Pharma...	3.32
DSP Healthcare Fund...	3.02
Kotak Small Cap Fund(G)	2.61
Kotak Business Cycl...	2.44
HDFC Pharma and Hea...	2.35
Motilal Oswal Small...	2.11
Bank of India Small...	1.89

Risk Disclosures on Derivatives

Smart Quotes

VIJAYA DIAGNOSTIC CENTRE LTD.